PARP1 and glioblastoma: As a whole and concluding, our findings suggest that PARP inhibition may be a promising strategy against GBM, as PARPi decreases cell viability [12], down-regulates pro-survival pathways, and importantly, compromises the GICs population stability (Figure 6).